Bank of New York Mellon Corp lessened its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,405,486 shares of the company's stock after selling 34,610 shares during the quarter. Bank of New York Mellon Corp owned 2.10% of Global Medical REIT worth $10,850,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its position in shares of Global Medical REIT by 54.3% during the third quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company's stock worth $2,298,000 after buying an additional 81,596 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Global Medical REIT by 228.9% in the 3rd quarter. Franklin Resources Inc. now owns 114,988 shares of the company's stock worth $1,073,000 after purchasing an additional 80,030 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Global Medical REIT by 158.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company's stock worth $1,195,000 after purchasing an additional 73,965 shares during the last quarter. Barclays PLC raised its stake in shares of Global Medical REIT by 87.1% in the 3rd quarter. Barclays PLC now owns 154,051 shares of the company's stock valued at $1,527,000 after purchasing an additional 71,704 shares in the last quarter. Finally, FMR LLC lifted its position in shares of Global Medical REIT by 39.5% during the third quarter. FMR LLC now owns 184,550 shares of the company's stock worth $1,829,000 after purchasing an additional 52,281 shares during the last quarter. Institutional investors and hedge funds own 57.52% of the company's stock.
Global Medical REIT Stock Down 0.3 %
Shares of Global Medical REIT stock opened at $8.68 on Friday. The business has a 50-day moving average price of $8.17 and a 200 day moving average price of $8.73. Global Medical REIT Inc. has a fifty-two week low of $7.33 and a fifty-two week high of $10.46. The firm has a market cap of $580.11 million, a P/E ratio of -433.53, a P/E/G ratio of 1.43 and a beta of 1.26. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26.
Global Medical REIT (NYSE:GMRE - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.21. The business had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.87 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. On average, sell-side analysts forecast that Global Medical REIT Inc. will post 0.81 earnings per share for the current fiscal year.
Global Medical REIT Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st will be issued a dividend of $0.21 per share. The ex-dividend date is Friday, March 21st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 9.68%. Global Medical REIT's dividend payout ratio (DPR) is 8,400.00%.
Global Medical REIT Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More
Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
